Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Mustafa Shakra, MD, FAAN (SKMC) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Taoufik Alsaadi, MD, FAAN (American Center for Psychiatry & Neurology ( ACPN)) | Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Alsaadi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. The institution of Dr. Alsaadi has received research support from Novartis. The institution of Dr. Alsaadi has received research support from Abbvie. The institution of Dr. Alsaadi has received research support from Pfizer. |
| Omar A. Khan, MD, PhD (Dept of Neuro/Wayne State Univ Sch of Med) | No disclosure on file |